Loading
Latest filing published 17 Jul 2026 for TelyRx Holdings Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ransom Langford discloses dealings in TelyRx Holdings Inc. to SEDI. In total, 3 filings cover trades dated from 31 March 2026 to 14 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 17 July 2026, the filings show an option exercise in TelyRx Holdings Inc. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations